サマリー

ぶどう膜炎治療薬の世界市場 2022-2026 年
Technavioは、ぶどう膜炎薬市場を監視しており、2022-2026年の間に2億6965万ドルの成長が見込まれ、予測期間中にCAGR5.9％で加速しています。当レポートでは、ぶどう膜炎治療薬市場の全体分析、市場規模と予測、トレンド、成長ドライバー、課題、さらに約 25 社のベンダーを網羅したベンダー分析を行っています。
現在の世界市場のシナリオ、最新動向とドライバー、市場全体の環境について最新の分析を提供しています。市場は、眼疾患および関連するぶどう膜炎のリスク要因の高い有病率、眼疾患の診断における最近の進歩、および強力なパイプラインによって牽引されています。
ぶどう膜炎薬市場の分析には、製品セグメントと地理的展望が含まれます。
Technavioのぶどう膜炎薬市場は、以下のように区分されています。
製品別
- 低分子化合物
- 生物学的製剤
地理的状況別
- 北アメリカ
- 欧州
- アジア
- その他の地域 (ROW)
本調査では、今後数年間におけるぶどう膜炎治療薬市場の成長を促進する主な理由の一つとして、遺伝子治療の発展を挙げています。また、特別な指定や併用療法の人気の高まりは、市場の大きな需要につながるでしょう。
Technavio 社は、複数のソースからのデータを調査、合成、および主要パラメータの分析によってまとめる方法で、市場の詳細図を提示します。ぶどう膜炎治療薬市場に関する当レポートは、以下の分野をカバーしています。
- ぶどう膜炎治療薬市場のサイジング
- ぶどう膜炎治療薬市場の予測
- ぶどう膜炎治療薬市場の産業分析
Technavio の強力なベンダー分析は、お客様の市場での地位向上に役立つよう設計されており、これに沿って本レポートでは、AbbVie Inc.、Alimera Sciences Inc.、Amgen Inc,Aurobindo Pharma Ltd.、Bausch Health Companies Inc.、Biogen Inc.、Cadila Pharmaceuticals Ltd.、EyePoint Pharmaceuticals Inc.、Hikma Pharmaceuticals Plc、Horizon Therapeutics Plc、Johnson and Johnson、Novartis AG、Pfizer Inc、Regenon Pharmaceuticals Inc.、Santen Pharmaceutical Co.Ltd.、Sebela Pharmaceuticals Inc.、Sun Pharmaceutical Industries Ltd.、Teva Pharmaceutical Industries Ltd.などです。また、ぶどう膜炎薬市場の分析レポートには、今後の動向や市場成長に影響を与える課題に関する情報も含まれています。これは、企業が戦略を立て、来るべき成長機会をすべて活用するのに役立つものです。
本調査は、業界の主要参加者からのインプットを含め、一次情報と二次情報の客観的な組み合わせを使用して実施しました。本レポートには、主要ベンダーの分析に加え、包括的な市場およびベンダーランドスケープが含まれています。本レポートの詳細については、https://www.technavio.com/report/uveitis-drugs-market-industry-analysis をご覧ください。
Technavioは、利益、価格、競争、プロモーションなどの主要パラメータの分析により、複数のソースからのデータの研究、合成、総括の方法により、市場の詳細な姿を提示します。また、業界の主要なインフルエンサーを特定することにより、市場の様々な側面を提示します。提示されるデータは包括的で信頼性が高く、一次および二次にわたる広範な調査の結果である。Technavioの市場調査レポートは、正確な市場成長を予測するために、完全な競争環境と、定性的および定量的調査を用いた詳細なベンダー選定方法および分析を提供します。

ページTOPに戻る

目次

• 1 Executive Summary
o 1.1 Market overview
o Exhibit 01: Executive Summary - Chart on Market Overview
o Exhibit 02: Executive Summary - Data Table on Market Overview
o Exhibit 03: Executive Summary - Chart on Global Market Characteristics
o Exhibit 04: Executive Summary - Chart on Market By Geographical Landscape
o Exhibit 05: Executive Summary - Chart on Market Segmentation by Product
o Exhibit 06: Executive Summary - Chart on Incremental Growth
o Exhibit 07: Executive Summary - Data Table on Incremental Growth
o Exhibit 08: Executive Summary - Chart on Vendor Market Positioning
• 2 Market Landscape
o 2.1 Market ecosystem
o Exhibit 09: Parent market
o Exhibit 10: Market Characteristics
• 3 Market Sizing
o 3.1 Market definition
o Exhibit 11: Offerings of vendors included in the market definition
o 3.2 Market segment analysis
o Exhibit 12: Market segments
o 3.3 Market size 2021
o 3.4 Market outlook: Forecast for 2021-2026
o Exhibit 13: Chart on Global - Market size and forecast 2021-2026 ($ million)
o Exhibit 14: Data Table on Global - Market size and forecast 2021-2026 ($ million)
o Exhibit 15: Chart on Global Market: Year-over-year growth 2021-2026 (%)
o Exhibit 16: Data Table on Global Market: Year-over-year growth 2021-2026 (%)
• 4 Five Forces Analysis
o 4.1 Five forces summary
o Exhibit 17: Five forces analysis - Comparison between 2021 and 2026
o 4.2 Bargaining power of buyers
o Exhibit 18: Chart on Bargaining power of buyers - Impact of key factors 2021 and 2026
o 4.3 Bargaining power of suppliers
o Exhibit 19: Bargaining power of suppliers - Impact of key factors in 2021 and 2026
o 4.4 Threat of new entrants
o Exhibit 20: Threat of new entrants - Impact of key factors in 2021 and 2026
o 4.5 Threat of substitutes
o Exhibit 21: Threat of substitutes - Impact of key factors in 2021 and 2026
o 4.6 Threat of rivalry
o Exhibit 22: Threat of rivalry - Impact of key factors in 2021 and 2026
o 4.7 Market condition
o Exhibit 23: Chart on Market condition - Five forces 2021 and 2026
• 5 Market Segmentation by Product
o 5.1 Market segments
o Exhibit 24: Chart on Product - Market share 2021-2026 (%)
o Exhibit 25: Data Table on Product - Market share 2021-2026 (%)
o 5.2 Comparison by Product
o Exhibit 26: Chart on Comparison by Product
o Exhibit 27: Data Table on Comparison by Product
o 5.3 Small molecules - Market size and forecast 2021-2026
o Exhibit 28: Chart on Small molecules - Market size and forecast 2021-2026 ($ million)
o Exhibit 29: Data Table on Small molecules - Market size and forecast 2021-2026 ($ million)
o Exhibit 30: Chart on Small molecules - Year-over-year growth 2021-2026 (%)
o Exhibit 31: Data Table on Small molecules - Year-over-year growth 2021-2026 (%)
o 5.4 Biologics - Market size and forecast 2021-2026
o Exhibit 32: Chart on Biologics - Market size and forecast 2021-2026 ($ million)
o Exhibit 33: Data Table on Biologics - Market size and forecast 2021-2026 ($ million)
o Exhibit 34: Chart on Biologics - Year-over-year growth 2021-2026 (%)
o Exhibit 35: Data Table on Biologics - Year-over-year growth 2021-2026 (%)
o 5.5 Market opportunity by Product
o Exhibit 36: Market opportunity by Product ($ million)
• 6 Customer Landscape
o 6.1 Customer landscape overview
o Exhibit 37: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
• 7 Geographic Landscape
o 7.1 Geographic segmentation
o Exhibit 38: Chart on Market share By Geographical Landscape 2021-2026 (%)
o Exhibit 39: Data Table on Market share By Geographical Landscape 2021-2026 (%)
o 7.2 Geographic comparison
o Exhibit 40: Chart on Geographic comparison
o Exhibit 41: Data Table on Geographic comparison
o 7.3 North America - Market size and forecast 2021-2026
o Exhibit 42: Chart on North America - Market size and forecast 2021-2026 ($ million)
o Exhibit 43: Data Table on North America - Market size and forecast 2021-2026 ($ million)
o Exhibit 44: Chart on North America - Year-over-year growth 2021-2026 (%)
o Exhibit 45: Data Table on North America - Year-over-year growth 2021-2026 (%)
o 7.4 Europe - Market size and forecast 2021-2026
o Exhibit 46: Chart on Europe - Market size and forecast 2021-2026 ($ million)
o Exhibit 47: Data Table on Europe - Market size and forecast 2021-2026 ($ million)
o Exhibit 48: Chart on Europe - Year-over-year growth 2021-2026 (%)
o Exhibit 49: Data Table on Europe - Year-over-year growth 2021-2026 (%)
o 7.5 Asia - Market size and forecast 2021-2026
o Exhibit 50: Chart on Asia - Market size and forecast 2021-2026 ($ million)
o Exhibit 51: Data Table on Asia - Market size and forecast 2021-2026 ($ million)
o Exhibit 52: Chart on Asia - Year-over-year growth 2021-2026 (%)
o Exhibit 53: Data Table on Asia - Year-over-year growth 2021-2026 (%)
o 7.6 Rest of World (ROW) - Market size and forecast 2021-2026
o Exhibit 54: Chart on Rest of World (ROW) - Market size and forecast 2021-2026 ($ million)
o Exhibit 55: Data Table on Rest of World (ROW) - Market size and forecast 2021-2026 ($ million)
o Exhibit 56: Chart on Rest of World (ROW) - Year-over-year growth 2021-2026 (%)
o Exhibit 57: Data Table on Rest of World (ROW) - Year-over-year growth 2021-2026 (%)
o 7.7 US - Market size and forecast 2021-2026
o Exhibit 58: Chart on US - Market size and forecast 2021-2026 ($ million)
o Exhibit 59: Data Table on US - Market size and forecast 2021-2026 ($ million)
o Exhibit 60: Chart on US - Year-over-year growth 2021-2026 (%)
o Exhibit 61: Data Table on US - Year-over-year growth 2021-2026 (%)
o 7.8 Germany - Market size and forecast 2021-2026
o Exhibit 62: Chart on Germany - Market size and forecast 2021-2026 ($ million)
o Exhibit 63: Data Table on Germany - Market size and forecast 2021-2026 ($ million)
o Exhibit 64: Chart on Germany - Year-over-year growth 2021-2026 (%)
o Exhibit 65: Data Table on Germany - Year-over-year growth 2021-2026 (%)
o 7.9 UK - Market size and forecast 2021-2026
o Exhibit 66: Chart on UK - Market size and forecast 2021-2026 ($ million)
o Exhibit 67: Data Table on UK - Market size and forecast 2021-2026 ($ million)
o Exhibit 68: Chart on UK - Year-over-year growth 2021-2026 (%)
o Exhibit 69: Data Table on UK - Year-over-year growth 2021-2026 (%)
o 7.10 Canada - Market size and forecast 2021-2026
o Exhibit 70: Chart on Canada - Market size and forecast 2021-2026 ($ million)
o Exhibit 71: Data Table on Canada - Market size and forecast 2021-2026 ($ million)
o Exhibit 72: Chart on Canada - Year-over-year growth 2021-2026 (%)
o Exhibit 73: Data Table on Canada - Year-over-year growth 2021-2026 (%)
o 7.11 China - Market size and forecast 2021-2026
o Exhibit 74: Chart on China - Market size and forecast 2021-2026 ($ million)
o Exhibit 75: Data Table on China - Market size and forecast 2021-2026 ($ million)
o Exhibit 76: Chart on China - Year-over-year growth 2021-2026 (%)
o Exhibit 77: Data Table on China - Year-over-year growth 2021-2026 (%)
o 7.12 Market opportunity By Geographical Landscape
o Exhibit 78: Market opportunity By Geographical Landscape ($ million)
• 8 Drivers, Challenges, and Trends
o 8.1 Market drivers
o 8.2 Market challenges
o 8.3 Impact of drivers and challenges
o Exhibit 79: Impact of drivers and challenges in 2021 and 2026
o 8.4 Market trends
• 9 Vendor Landscape
o 9.1 Overview
o 9.2 Vendor landscape
o Exhibit 80: Overview on Criticality of inputs and Factors of differentiation
o 9.3 Landscape disruption
o Exhibit 81: Overview on factors of disruption
o 9.4 Industry risks
o Exhibit 82: Impact of key risks on business
• 10 Vendor Analysis
o 10.1 Vendors covered
o Exhibit 83: Vendors covered
o 10.2 Market positioning of vendors
o Exhibit 84: Matrix on vendor position and classification
o 10.3 AbbVie Inc.
o Exhibit 85: AbbVie Inc. - Overview
o Exhibit 86: AbbVie Inc. - Product / Service
o Exhibit 87: AbbVie Inc. - Key offerings
o 10.4 Alimera Sciences Inc.
o Exhibit 88: Alimera Sciences Inc. - Overview
o Exhibit 89: Alimera Sciences Inc. - Product / Service
o Exhibit 90: Alimera Sciences Inc. - Key offerings
o 10.5 Amgen Inc.
o Exhibit 91: Amgen Inc. - Overview
o Exhibit 92: Amgen Inc. - Product / Service
o Exhibit 93: Amgen Inc. - Key offerings
o 10.6 Biogen Inc.
o Exhibit 94: Biogen Inc. - Overview
o Exhibit 95: Biogen Inc. - Product / Service
o Exhibit 96: Biogen Inc. - Key offerings
o 10.7 Cadila Pharmaceuticals Ltd.
o Exhibit 97: Cadila Pharmaceuticals Ltd. - Overview
o Exhibit 98: Cadila Pharmaceuticals Ltd. - Business segments
o Exhibit 99: Cadila Pharmaceuticals Ltd. - Key offerings
o Exhibit 100: Cadila Pharmaceuticals Ltd. - Segment focus
o 10.8 EyePoint Pharmaceuticals Inc.
o Exhibit 101: EyePoint Pharmaceuticals Inc. - Overview
o Exhibit 102: EyePoint Pharmaceuticals Inc. - Product / Service
o Exhibit 103: EyePoint Pharmaceuticals Inc. - Key offerings
o 10.9 Johnson and Johnson
o Exhibit 104: Johnson and Johnson - Overview
o Exhibit 105: Johnson and Johnson - Business segments
o Exhibit 106: Johnson and Johnson - Key news
o Exhibit 107: Johnson and Johnson - Key offerings
o Exhibit 108: Johnson and Johnson - Segment focus
o 10.10 Novartis AG
o Exhibit 109: Novartis AG - Overview
o Exhibit 110: Novartis AG - Business segments
o Exhibit 111: Novartis AG - Key offerings
o Exhibit 112: Novartis AG - Segment focus
o 10.11 Pfizer Inc.
o Exhibit 113: Pfizer Inc. - Overview
o Exhibit 114: Pfizer Inc. - Product / Service
o Exhibit 115: Pfizer Inc. - Key news
o Exhibit 116: Pfizer Inc. - Key offerings
o 10.12 Regeneron Pharmaceuticals Inc.
o Exhibit 117: Regeneron Pharmaceuticals Inc. - Overview
o Exhibit 118: Regeneron Pharmaceuticals Inc. - Product / Service
o Exhibit 119: Regeneron Pharmaceuticals Inc. - Key offerings
• 11 Appendix
o 11.1 Scope of the report
o 11.2 Inclusions and exclusions checklist
o Exhibit 120: Inclusions checklist
o Exhibit 121: Exclusions checklist
o 11.3 Currency conversion rates for US$
o Exhibit 122: Currency conversion rates for US$
o 11.4 Research methodology
o Exhibit 123: Research methodology
o Exhibit 124: Validation techniques employed for market sizing
o Exhibit 125: Information sources
o 11.5 List of abbreviations
o Exhibit 126: List of abbreviations


Exhibits:
Exhibits1: Executive Summary - Chart on Market Overview
Exhibits2: Executive Summary - Data Table on Market Overview
Exhibits3: Executive Summary - Chart on Global Market Characteristics
Exhibits4: Executive Summary - Chart on Market By Geographical Landscape
Exhibits5: Executive Summary - Chart on Market Segmentation by Product
Exhibits6: Executive Summary - Chart on Incremental Growth
Exhibits7: Executive Summary - Data Table on Incremental Growth
Exhibits8: Executive Summary - Chart on Vendor Market Positioning
Exhibits9: Parent market
Exhibits10: Market Characteristics
Exhibits11: Offerings of vendors included in the market definition
Exhibits12: Market segments
Exhibits13: Chart on Global - Market size and forecast 2021-2026 ($ million)
Exhibits14: Data Table on Global - Market size and forecast 2021-2026 ($ million)
Exhibits15: Chart on Global Market: Year-over-year growth 2021-2026 (%)
Exhibits16: Data Table on Global Market: Year-over-year growth 2021-2026 (%)
Exhibits17: Five forces analysis - Comparison between 2021 and 2026
Exhibits18: Chart on Bargaining power of buyers - Impact of key factors 2021 and 2026
Exhibits19: Bargaining power of suppliers - Impact of key factors in 2021 and 2026
Exhibits20: Threat of new entrants - Impact of key factors in 2021 and 2026
Exhibits21: Threat of substitutes - Impact of key factors in 2021 and 2026
Exhibits22: Threat of rivalry - Impact of key factors in 2021 and 2026
Exhibits23: Chart on Market condition - Five forces 2021 and 2026
Exhibits24: Chart on Product - Market share 2021-2026 (%)
Exhibits25: Data Table on Product - Market share 2021-2026 (%)
Exhibits26: Chart on Comparison by Product
Exhibits27: Data Table on Comparison by Product
Exhibits28: Chart on Small molecules - Market size and forecast 2021-2026 ($ million)
Exhibits29: Data Table on Small molecules - Market size and forecast 2021-2026 ($ million)
Exhibits30: Chart on Small molecules - Year-over-year growth 2021-2026 (%)
Exhibits31: Data Table on Small molecules - Year-over-year growth 2021-2026 (%)
Exhibits32: Chart on Biologics - Market size and forecast 2021-2026 ($ million)
Exhibits33: Data Table on Biologics - Market size and forecast 2021-2026 ($ million)
Exhibits34: Chart on Biologics - Year-over-year growth 2021-2026 (%)
Exhibits35: Data Table on Biologics - Year-over-year growth 2021-2026 (%)
Exhibits36: Market opportunity by Product ($ million)
Exhibits37: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
Exhibits38: Chart on Market share By Geographical Landscape 2021-2026 (%)
Exhibits39: Data Table on Market share By Geographical Landscape 2021-2026 (%)
Exhibits40: Chart on Geographic comparison
Exhibits41: Data Table on Geographic comparison
Exhibits42: Chart on North America - Market size and forecast 2021-2026 ($ million)
Exhibits43: Data Table on North America - Market size and forecast 2021-2026 ($ million)
Exhibits44: Chart on North America - Year-over-year growth 2021-2026 (%)
Exhibits45: Data Table on North America - Year-over-year growth 2021-2026 (%)
Exhibits46: Chart on Europe - Market size and forecast 2021-2026 ($ million)
Exhibits47: Data Table on Europe - Market size and forecast 2021-2026 ($ million)
Exhibits48: Chart on Europe - Year-over-year growth 2021-2026 (%)
Exhibits49: Data Table on Europe - Year-over-year growth 2021-2026 (%)
Exhibits50: Chart on Asia - Market size and forecast 2021-2026 ($ million)
Exhibits51: Data Table on Asia - Market size and forecast 2021-2026 ($ million)
Exhibits52: Chart on Asia - Year-over-year growth 2021-2026 (%)
Exhibits53: Data Table on Asia - Year-over-year growth 2021-2026 (%)
Exhibits54: Chart on Rest of World (ROW) - Market size and forecast 2021-2026 ($ million)
Exhibits55: Data Table on Rest of World (ROW) - Market size and forecast 2021-2026 ($ million)
Exhibits56: Chart on Rest of World (ROW) - Year-over-year growth 2021-2026 (%)
Exhibits57: Data Table on Rest of World (ROW) - Year-over-year growth 2021-2026 (%)
Exhibits58: Chart on US - Market size and forecast 2021-2026 ($ million)
Exhibits59: Data Table on US - Market size and forecast 2021-2026 ($ million)
Exhibits60: Chart on US - Year-over-year growth 2021-2026 (%)
Exhibits61: Data Table on US - Year-over-year growth 2021-2026 (%)
Exhibits62: Chart on Germany - Market size and forecast 2021-2026 ($ million)
Exhibits63: Data Table on Germany - Market size and forecast 2021-2026 ($ million)
Exhibits64: Chart on Germany - Year-over-year growth 2021-2026 (%)
Exhibits65: Data Table on Germany - Year-over-year growth 2021-2026 (%)
Exhibits66: Chart on UK - Market size and forecast 2021-2026 ($ million)
Exhibits67: Data Table on UK - Market size and forecast 2021-2026 ($ million)
Exhibits68: Chart on UK - Year-over-year growth 2021-2026 (%)
Exhibits69: Data Table on UK - Year-over-year growth 2021-2026 (%)
Exhibits70: Chart on Canada - Market size and forecast 2021-2026 ($ million)
Exhibits71: Data Table on Canada - Market size and forecast 2021-2026 ($ million)
Exhibits72: Chart on Canada - Year-over-year growth 2021-2026 (%)
Exhibits73: Data Table on Canada - Year-over-year growth 2021-2026 (%)
Exhibits74: Chart on China - Market size and forecast 2021-2026 ($ million)
Exhibits75: Data Table on China - Market size and forecast 2021-2026 ($ million)
Exhibits76: Chart on China - Year-over-year growth 2021-2026 (%)
Exhibits77: Data Table on China - Year-over-year growth 2021-2026 (%)
Exhibits78: Market opportunity By Geographical Landscape ($ million)
Exhibits79: Impact of drivers and challenges in 2021 and 2026
Exhibits80: Overview on Criticality of inputs and Factors of differentiation
Exhibits81: Overview on factors of disruption
Exhibits82: Impact of key risks on business
Exhibits83: Vendors covered
Exhibits84: Matrix on vendor position and classification
Exhibits85: AbbVie Inc. - Overview
Exhibits86: AbbVie Inc. - Product / Service
Exhibits87: AbbVie Inc. - Key offerings
Exhibits88: Alimera Sciences Inc. - Overview
Exhibits89: Alimera Sciences Inc. - Product / Service
Exhibits90: Alimera Sciences Inc. - Key offerings
Exhibits91: Amgen Inc. - Overview
Exhibits92: Amgen Inc. - Product / Service
Exhibits93: Amgen Inc. - Key offerings
Exhibits94: Biogen Inc. - Overview
Exhibits95: Biogen Inc. - Product / Service
Exhibits96: Biogen Inc. - Key offerings
Exhibits97: Cadila Pharmaceuticals Ltd. - Overview
Exhibits98: Cadila Pharmaceuticals Ltd. - Business segments
Exhibits99: Cadila Pharmaceuticals Ltd. - Key offerings
Exhibits100: Cadila Pharmaceuticals Ltd. - Segment focus
Exhibits101: EyePoint Pharmaceuticals Inc. - Overview
Exhibits102: EyePoint Pharmaceuticals Inc. - Product / Service
Exhibits103: EyePoint Pharmaceuticals Inc. - Key offerings
Exhibits104: Johnson and Johnson - Overview
Exhibits105: Johnson and Johnson - Business segments
Exhibits106: Johnson and Johnson - Key news
Exhibits107: Johnson and Johnson - Key offerings
Exhibits108: Johnson and Johnson - Segment focus
Exhibits109: Novartis AG - Overview
Exhibits110: Novartis AG - Business segments
Exhibits111: Novartis AG - Key offerings
Exhibits112: Novartis AG - Segment focus
Exhibits113: Pfizer Inc. - Overview
Exhibits114: Pfizer Inc. - Product / Service
Exhibits115: Pfizer Inc. - Key news
Exhibits116: Pfizer Inc. - Key offerings
Exhibits117: Regeneron Pharmaceuticals Inc. - Overview
Exhibits118: Regeneron Pharmaceuticals Inc. - Product / Service
Exhibits119: Regeneron Pharmaceuticals Inc. - Key offerings
Exhibits120: Inclusions checklist
Exhibits121: Exclusions checklist
Exhibits122: Currency conversion rates for US$
Exhibits123: Research methodology
Exhibits124: Validation techniques employed for market sizing
Exhibits125: Information sources
Exhibits126: List of abbreviations